CSF2 and melanoma: Additional strategies can include the colony-stimulating factor (CSF)-1R inhibitor PLX3397 that has been shown to reduce myeloid cell infiltration and enhance adoptive cell transfer immunotherapy in BRAFV600E-driven melanoma genesis in mice [30].